BIOMAT Database Logo BIOMAT Database Logo

The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. 1995

I Stansfield, and K M Jones, and V V Kushnirov, and A R Dagkesamanskaya, and A I Poznyakovski, and S V Paushkin, and C R Nierras, and B S Cox, and M D Ter-Avanesyan, and M F Tuite
Research School of Biosciences, University of Kent, Canterbury, UK.

The product of the yeast SUP45 gene (Sup45p) is highly homologous to the Xenopus eukaryote release factor 1 (eRF1), which has release factor activity in vitro. We show, using the two-hybrid system, that in Saccharomyces cerevisiae Sup45p and the product of the SUP35 gene (Sup35p) interact in vivo. The ability of Sup45p C-terminally tagged with (His)6 to specifically precipitate Sup35p from a cell lysate was used to confirm this interaction in vitro. Although overexpression of either the SUP45 or SUP35 genes alone did not reduce the efficiency of codon-specific tRNA nonsense suppression, the simultaneous overexpression of both the SUP35 and SUP45 genes in nonsense suppressor tRNA-containing strains produced an antisuppressor phenotype. These data are consistent with Sup35p and Sup45p forming a complex with release factor properties. Furthermore, overexpression of either Xenopus or human eRF1 (SUP45) genes also resulted in anti-suppression only if that strain was also overexpressing the yeast SUP35 gene. Antisuppression is a characteristic phenotype associated with overexpression of both prokaryote and mitochondrial release factors. We propose that Sup45p and Sup35p interact to form a release factor complex in yeast and that Sup35p, which has GTP binding sequence motifs in its C-terminal domain, provides the GTP hydrolytic activity which is a demonstrated requirement of the eukaryote translation termination reaction.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009838 Oligodeoxyribonucleotides A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Oligodeoxynucleotide,Oligodeoxyribonucleotide,Oligodeoxynucleotides
D010443 Peptide Chain Termination, Translational A process of GENETIC TRANSLATION whereby the terminal amino acid is added to a lengthening polypeptide. This termination process is signaled from the MESSENGER RNA, by one of three termination codons (CODON, TERMINATOR) that immediately follows the last amino acid-specifying CODON. Chain Termination, Peptide, Translational,Protein Biosynthesis Termination,Protein Chain Termination, Translational,Protein Translation Termination,Translation Termination, Genetic,Translation Termination, Protein,Translational Peptide Chain Termination,Translational Termination, Protein,Biosynthesis Termination, Protein,Genetic Translation Termination,Protein Translational Termination,Termination, Genetic Translation,Termination, Protein Biosynthesis,Termination, Protein Translation,Termination, Protein Translational
D010454 Peptide Termination Factors Proteins that are involved in the peptide chain termination reaction (PEPTIDE CHAIN TERMINATION, TRANSLATIONAL) on RIBOSOMES. They include codon-specific class-I release factors, which recognize stop signals (TERMINATOR CODON) in the MESSENGER RNA; and codon-nonspecific class-II release factors. Termination Release Factor,Factor, Termination Release,Factors, Peptide Termination,Release Factor, Termination,Termination Factors, Peptide
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011328 Prions Small proteinaceous infectious particles which resist inactivation by procedures that modify NUCLEIC ACIDS and contain an abnormal isoform of a cellular protein which is a major and necessary component. The abnormal (scrapie) isoform is PrPSc (PRPSC PROTEINS) and the cellular isoform PrPC (PRPC PROTEINS). The primary amino acid sequence of the two isoforms is identical. Human diseases caused by prions include CREUTZFELDT-JAKOB SYNDROME; GERSTMANN-STRAUSSLER SYNDROME; and INSOMNIA, FATAL FAMILIAL. Mink Encephalopathy Virus,Prion,Encephalopathy Virus, Mink
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005656 Fungal Proteins Proteins found in any species of fungus. Fungal Gene Products,Fungal Gene Proteins,Fungal Peptides,Gene Products, Fungal,Yeast Proteins,Gene Proteins, Fungal,Peptides, Fungal,Proteins, Fungal
D005800 Genes, Fungal The functional hereditary units of FUNGI. Fungal Genes,Fungal Gene,Gene, Fungal

Related Publications

I Stansfield, and K M Jones, and V V Kushnirov, and A R Dagkesamanskaya, and A I Poznyakovski, and S V Paushkin, and C R Nierras, and B S Cox, and M D Ter-Avanesyan, and M F Tuite
[Characterization of missense mutations in the SUP45 gene of Saccharomyces cerevisiae encoding translation termination factor eRF1].
May 2004, Genetika,
I Stansfield, and K M Jones, and V V Kushnirov, and A R Dagkesamanskaya, and A I Poznyakovski, and S V Paushkin, and C R Nierras, and B S Cox, and M D Ter-Avanesyan, and M F Tuite
Transcriptional regulation of SUP35 and SUP45 in Saccharomyces cerevisiae.
October 1997, Yeast (Chichester, England),
I Stansfield, and K M Jones, and V V Kushnirov, and A R Dagkesamanskaya, and A I Poznyakovski, and S V Paushkin, and C R Nierras, and B S Cox, and M D Ter-Avanesyan, and M F Tuite
[Interaction of ATP17 gene with SUP45 and SUP35 genes in Saccharomyces cerevisiae yeast].
May 2000, Genetika,
I Stansfield, and K M Jones, and V V Kushnirov, and A R Dagkesamanskaya, and A I Poznyakovski, and S V Paushkin, and C R Nierras, and B S Cox, and M D Ter-Avanesyan, and M F Tuite
Recessive mutations in SUP35 and SUP45 genes coding for translation release factors affect chromosome stability in Saccharomyces cerevisiae.
May 2000, Current genetics,
I Stansfield, and K M Jones, and V V Kushnirov, and A R Dagkesamanskaya, and A I Poznyakovski, and S V Paushkin, and C R Nierras, and B S Cox, and M D Ter-Avanesyan, and M F Tuite
Variants in SUP45 and TRM10 underlie natural variation in translation termination efficiency in Saccharomyces cerevisiae.
July 2011, PLoS genetics,
I Stansfield, and K M Jones, and V V Kushnirov, and A R Dagkesamanskaya, and A I Poznyakovski, and S V Paushkin, and C R Nierras, and B S Cox, and M D Ter-Avanesyan, and M F Tuite
Sensitivity of sup35 and sup45 suppressor mutants in Saccharomyces cerevisiae to the anti-microtubule drug benomyl.
June 1996, Current genetics,
I Stansfield, and K M Jones, and V V Kushnirov, and A R Dagkesamanskaya, and A I Poznyakovski, and S V Paushkin, and C R Nierras, and B S Cox, and M D Ter-Avanesyan, and M F Tuite
The translation termination factor eRF1 (Sup45p) of Saccharomyces cerevisiae is required for pseudohyphal growth and invasion.
June 2015, FEMS yeast research,
I Stansfield, and K M Jones, and V V Kushnirov, and A R Dagkesamanskaya, and A I Poznyakovski, and S V Paushkin, and C R Nierras, and B S Cox, and M D Ter-Avanesyan, and M F Tuite
The C-terminus of eRF1 defines a functionally important domain for translation termination in Saccharomyces cerevisiae.
May 1999, Molecular microbiology,
I Stansfield, and K M Jones, and V V Kushnirov, and A R Dagkesamanskaya, and A I Poznyakovski, and S V Paushkin, and C R Nierras, and B S Cox, and M D Ter-Avanesyan, and M F Tuite
The role of translation termination factor eRF1 in the regulation of pseudohyphal growth in Saccharomyces cerevisiae cells.
January 2010, Doklady. Biochemistry and biophysics,
I Stansfield, and K M Jones, and V V Kushnirov, and A R Dagkesamanskaya, and A I Poznyakovski, and S V Paushkin, and C R Nierras, and B S Cox, and M D Ter-Avanesyan, and M F Tuite
N-terminal extension of Saccharomyces cerevisiae translation termination factor eRF3 influences the suppression efficiency of sup35 mutations.
May 2007, FEMS yeast research,
Copied contents to your clipboard!